Clinical Trials
Dermatology Clinical Trials Unit
Principal Investigators: Ann Martin, M.D.; Susan J. Bayliss, M.D.
The Dermatology Clinical Trials Unit is nationally recognized for developing and participating in clinical therapeutic trials. Clinical trials allows our patients to be exposed to experimental therapeutics. The trials unit is experienced in all areas of dermatologic clinical research from pre-Phase I to Phase IV. We are currently participating in a broad range of clinical trials of novel therapeutics for psoriasis, skin cancer, and acne. The trials unit draws on the dermatology division's vast clinical experience (over 30,000 patient visits annually).
Current Clinical Trials
A Randomized Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa. Principal Investigator:Susan J. Bayliss, M.D.
For further information on any of these trials,
please contact one of the following:
Mary Tabacchi
Clinical Research Coordinator
Tel: (314) 362-8171
